| Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
|---|
| 07/25/2012 | CN101366849B Detection and content determination method for traditional Chinese medicine citrus aurantium |
| 07/25/2012 | CN101288760B Externally-used drug for treating appendicitis |
| 07/25/2012 | CN101181504B Chinese medicine combination for curing gastralgia |
| 07/25/2012 | CN101161808B Medicine wine containing total scorpion or scorpion toxin, or dioscorea nipponica |
| 07/24/2012 | US8227620 Pharmaceutical compounds |
| 07/24/2012 | US8227570 Modified gherlin peptides |
| 07/24/2012 | US8227474 Sodium channel blockers |
| 07/24/2012 | CA2690483C The use of anti-histaminics for acute reduction of elevated intracranial pressure |
| 07/24/2012 | CA2547625C Crystals of phenylalanine derivatives and production methods thereof |
| 07/24/2012 | CA2486252C Methods for screening for agents that modulate hepatocellular carcinoma development |
| 07/24/2012 | CA2476065C Inhibitors of histone deacetylase |
| 07/24/2012 | CA2471822C Cell-specific herpes simplex virus expression/replication vector comprising icp4 and human calponin gene promoter |
| 07/24/2012 | CA2458146C Use of milk serum apoproteins in the prophylaxis or treatment of microbial or viral infection |
| 07/24/2012 | CA2412172C 1,2-dihydropyridine compounds, manufacturing method thereof and use thereof |
| 07/24/2012 | CA2386716C Magnesium salt of s-omeprazole |
| 07/19/2012 | WO2012096718A2 Composition comprising hepatic therapeutic active for treating liver diseases, certain cancers, and liver health maintenance |
| 07/19/2012 | WO2012096411A1 Method for preventing or treating intractable inflammatory bowel disease |
| 07/19/2012 | WO2012096108A1 Suppressor for increase in blood gip level, suppressor for increase in blood insulin level, postprandial blood triglyceride level reducing agent, and suppressor for increase in blood glucose level |
| 07/19/2012 | WO2012095774A1 Self assembled nanostructured saliva substitutes |
| 07/19/2012 | WO2012095521A1 Bace-2 inhibitors for the treatment of metabolic disorders |
| 07/19/2012 | WO2012069658A3 Immunomodulatory compositions comprising hydralazine for the treatment gastrointestinal disorders |
| 07/19/2012 | WO2012067482A3 ORALLY ADMINISTERED PHARMACEUTICAL COMPOSITION AND PREPARATION METHOD THEREOF, FOR THE PREVENTION AND TREATMENT OF IRRITABLE BOWEL SYNDROME, COMPRISING AN INTESTINAL MOTILITY MODIFIER AND α-D-GALACTOSIDASE |
| 07/19/2012 | WO2012065106A3 Compounds and related methods for manipulating parp-1-dependent cell death |
| 07/19/2012 | WO2012057417A8 Composition containing okamejei kenojei extract |
| 07/19/2012 | WO2012047826A9 Methods of use of small molecule modulators of hepatocyte growth factor (scatter factor) activity |
| 07/19/2012 | US20120184610 Methods and formulations for treating ineffective or decreased esophagal motility |
| 07/19/2012 | US20120184605 Methods and compositions for treating hiv-associated diarrhea |
| 07/19/2012 | US20120184597 Oligoribonucleotides and methods of use thereof for treatment of alopecia, acute renal failure and other diseases |
| 07/19/2012 | US20120184594 Phenylpyrrolidine compounds |
| 07/19/2012 | US20120184585 Fatty acid niacin conjugates and their uses |
| 07/19/2012 | US20120184583 Modulators of atp-binding cassette transporters |
| 07/19/2012 | US20120184582 Novel compounds effective as xanthine oxidase inhibitors, method for preparing the same, and pharmaceutical composition containing the same |
| 07/19/2012 | US20120184579 Quinolines and Their Therapeutic Use |
| 07/19/2012 | US20120184578 Composition comprising hepatic therapeutic active for treating liver diseases, certain cancers and liver health maintenance |
| 07/19/2012 | US20120184571 Quinazolinone derivatives useful as vanilloid antagonists |
| 07/19/2012 | US20120184569 A3 adenosine receptor agonists and antagonists |
| 07/19/2012 | US20120184537 [1,4]-benzodiazepines as vasopressin v2 receptor antagonists |
| 07/19/2012 | US20120184534 Tri-cyclic pyrazolopyridine kinase inhibitors |
| 07/19/2012 | US20120184533 Small molecule inhibitors of parp activity |
| 07/19/2012 | US20120184532 Galantamine amino acid and peptide prodrugs and uses thereof |
| 07/19/2012 | US20120184524 Pyrazolopyridine kinase inhibitors |
| 07/19/2012 | US20120184523 C-Met Modulators and Method of Use |
| 07/19/2012 | US20120184520 Glycine compound |
| 07/19/2012 | US20120184518 Methods of treating or preventing an inflammatory disease or condition using glutaminyl cyclase inhibitors |
| 07/19/2012 | US20120184516 sGC Stimulators |
| 07/19/2012 | US20120184511 Novel Pharmaceutical Composition Comprising a Macrolide Immunosuppressant Drug |
| 07/19/2012 | US20120184483 Lactoferrin and neuronal health and development in the infant gut |
| 07/19/2012 | US20120183627 Compositions for the treatment of hemorrhoids and related diseases |
| 07/19/2012 | US20120183579 Compounds for inflammation and immune-related uses |
| 07/19/2012 | US20120183577 Compositions useful as inhibitors of protein kinases |
| 07/19/2012 | US20120183565 Fully human antibodies to btla |
| 07/19/2012 | US20120183561 Alpha-4-beta-7 heterodimer specific antagonist antibody |
| 07/19/2012 | US20120183558 Antibody molecules which bind il-17a and il-17f |
| 07/19/2012 | US20120183549 Chemokine receptor binding polypeptides |
| 07/19/2012 | US20120183548 IL-27 Antagonists for Treating Inflammatory Diseases |
| 07/19/2012 | US20120183543 Diagnostic biomarkers for fibrotic disorders |
| 07/19/2012 | US20120183538 Sparc antisense compositions and uses thereof |
| 07/19/2012 | US20120183526 Composition for preventing or treating liver toxicity comprising galgeuntang or lactic acid bacteria fermented galgeuntang |
| 07/19/2012 | US20120183513 Lactobacillus Supplement for Alleviating Type I Diabetes |
| 07/19/2012 | US20120183506 Prevention and treatment of allergic diarrhoea |
| 07/19/2012 | CA2824805A1 Il-27 antagonists for treating inflammatory diseases |
| 07/19/2012 | CA2824493A1 Bace-2 inhibitors for the treatment of metabolic disorders |
| 07/19/2012 | CA2817757A1 Composition comprising hepatic therapeutic active for treating liver diseases, certain cancers, and liver health maintenance |
| 07/18/2012 | EP2476758A1 Method for prediction of therapeutic effect on chronic hepatitis c |
| 07/18/2012 | EP2476682A1 8-oxodihydropurine derivative |
| 07/18/2012 | EP2476680A1 (1-Azinone)-Substituted Pyridoindoles |
| 07/18/2012 | EP2476678A1 Substituted carbonyl compounds |
| 07/18/2012 | EP2476442A1 Root canal filler for non-extracted tooth and non-extraction method for regenerating dental tissue |
| 07/18/2012 | EP2476424A1 Orally administrable tablet for intestinal lavage |
| 07/18/2012 | EP2476423A1 Antacid and laxative tablet |
| 07/18/2012 | EP2476421A1 Hyaluronic acid based mucoadhesive therapeutic composition for the prevention and treatment of epithelial and mucosal lesions of the human body |
| 07/18/2012 | EP2475392A1 Methods for treating irritable bowel syndrome (ibs) |
| 07/18/2012 | EP2475370A1 Screening method and therapy with agonists of ddah i |
| 07/18/2012 | EP1982705B1 Pharmaceutical composition containing chenopodium ambrosioides extract and its preparation process and application |
| 07/18/2012 | EP1470148B1 Double-stranded oligonucleotides |
| 07/18/2012 | EP1432735B1 Antagonistic anti-htnfsf13b human antibodies |
| 07/18/2012 | CN1935260B Human antibodies that bind human tnfalpha |
| 07/18/2012 | CN1753886B Process for producing acid adduct salt of polyacidic base compound |
| 07/18/2012 | CN1531533B Crystalline form of omeprazole |
| 07/18/2012 | CN1440408B Inhibitors of human phosphatidyl-inositol 3-kinase delta |
| 07/18/2012 | CN102597003A Compositions and methods for treating inflammatory disorders |
| 07/18/2012 | CN102596982A Agent for inhibiting thickening of peritoneal membrane |
| 07/18/2012 | CN102596949A 8-azabicyclo[3.2.1]octane-8-carboxamide derivative |
| 07/18/2012 | CN102596270A Root canal filler for non-extracted tooth and non-extraction method for regenerating dental tissue |
| 07/18/2012 | CN102596256A Composition for treatment of pancreatic cancer |
| 07/18/2012 | CN102596252A Gastric retentive pharmaceutical compositions for immediate and extended release of acetaminophen |
| 07/18/2012 | CN102596244A 丙型肝炎病毒疫苗组合物 HCV vaccine composition |
| 07/18/2012 | CN102596237A Method of treating eosinophilic esophagitis |
| 07/18/2012 | CN102596214A Composition for alleviating fatty liver |
| 07/18/2012 | CN102596188A Methods of increasing liver proliferation |
| 07/18/2012 | CN102595937A Health-beneficial preparation and production method |
| 07/18/2012 | CN102595936A Nutritional compositions including theanine and exogenous nucleotides |
| 07/18/2012 | CN102595934A Nutritional composition for promoting gut microbiota balance and health |
| 07/18/2012 | CN102586377A Concentrate containing carotenoid monomer and preparation method as well as application thereof |
| 07/18/2012 | CN102586129A Oil producing rhodococcus sp.RHA-MLDS having MLDS (Multiple Low Dose Streptozotocin) gene knocked out and purpose of oil producing rhodococcus sp.RHA-MLDS |
| 07/18/2012 | CN102586066A Health-care wine and preparation method thereof |
| 07/18/2012 | CN102586064A Nutrition wine for nourishing yin and invigorating kidney |
| 07/18/2012 | CN102586063A Middle-aged health care wine |
| 07/18/2012 | CN102586006A Method for deeply developing and comprehensively utilizing medicinal and edible plant sea buckthorn |
| 07/18/2012 | CN102585029A Preparation method and application of physiologically active notoginseng polysaccharide |